Latest filing published 11 Feb 2026 for Adma Biologics, INC.. Read the official filing
No signal scores available.
Alison Cecily Finger has filed trades across 3 companies (mainly through SEC (Form 4)), most often in bluebird bio, Inc., Adma Biologics, Inc. and Decibel Therapeutics, Inc. In total, 32 filings cover trades dated from 20 August 2018 to 9 February 2026.
Sales make up the whole of the open-market record (24 sales, €315k). Other entries cover 7 share grants.
The latest filing, published on 11 February 2026, reports a share grant in Adma Biologics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations